EVALUATION OF THE ROLE OF ITPA GENE VARIANT IN PROTECTION AGAINST ANEMIA INDUCED BY PEGYLATED INTERFERON-A AND RIBAVIRIN THERAPY IN EGYPTIAN HEPATITIS C PATIENTS
Heba Moustafa Mohamed Elsharawy;
Abstract
Hepatitis C virus (HCV) infection is an important public health problem. In more than 80% of infected person HCV infection can induce persistent hepatic injury which leads to disease progression from periportal inflammation to chronic hepatitis with bri
Other data
| Title | EVALUATION OF THE ROLE OF ITPA GENE VARIANT IN PROTECTION AGAINST ANEMIA INDUCED BY PEGYLATED INTERFERON-A AND RIBAVIRIN THERAPY IN EGYPTIAN HEPATITIS C PATIENTS | Other Titles | تقييم دور جين متغير إينوزين تراى فوسفات (ITPA) في الحماية من فقر الدم الناجم عن مضاد الفيروسات (عقار الانترفيرون) وريبافيرين فى المرضى المصريين المصابين بالالتهاب الكبدى الوبائى (سى) | Authors | Heba Moustafa Mohamed Elsharawy | Keywords | EVALUATION OF THE ROLE OF ITPA GENE VARIANT IN PROTECTION AGAINST ANEMIA INDUCED BY PEGYLATED INTERFERON-A AND RIBAVIRIN THERAPY IN EGYPTIAN HEPATITIS C PATIENTS | Issue Date | 2013 | Description | Hepatitis C virus (HCV) infection is an important public health problem. In more than 80% of infected person HCV infection can induce persistent hepatic injury which leads to disease progression from periportal inflammation to chronic hepatitis with bri |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 123841G3370.pdf | 120.76 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.